Vascular Biogenics, Ltd. IPO Research Information

Vascular Biogenics, Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Vascular Biogenics, Ltd., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Vascular Biogenics, Ltd.	VBLT - NASDAQ	$13.00-$15.00	$6.00	$6.02	6.66 million	10/1/2014
Underwriter(s): Deutsche Bank Securities
Co-Manager(s): JMP Securities, Oppenheimer & Co.
Industry: Health Care
Filing(s): Filed 2014-06-07 Underwriters Added 2014-06-26 Terms Added 2014-07-16

Vascular Biogenics, Ltd. Quote & Chart - Click for current quote - VBLT

About Vascular Biogenics, Ltd. (adapted from Vascular Biogenics, Ltd. prospectus):
They are a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases.

This description is adapted from Vascular Biogenics, Ltd. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Vascular Biogenics, Ltd. "VBLT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.